Clinical Trials Directory

Trials / Unknown

UnknownNCT04910217

Robot-Assisted Gait Therapy in the Subacute Phase of First Ischemic Stroke

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
University Hospital Ostrava · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Robot-assisted gait training (RAGT) represents a modern concept of neurorehabilitation in stroke patients. This single-center randomized parallel-group neurorehabilitation trial with blinded primary outcome assessment is aimed at patients after the first-ever ischaemic stroke in the anterior or posterior cerebral circulation.

Detailed description

The main aim is to determine, whether the RAGT by using the Lokomat exoskeleton device (Hoccoma, Switzerland) plus the protocol-defined conventional rehabilitation versus conventional rehabilitation improves the gait of post-stroke patients after 6 months. Both groups are treated with the protocol-defined rehabilitation (ergotherapy and physiotherapy) for 60 min 5 times a week, a total of 15 times within 3 weeks (a total of 1200 min). The Lokowalkers group undergoes the RAGT using the Lokomat Pro Freed device for 20-50 minutes 5 times a week for a total of 15 times for 3 weeks (a total of 1800 minutes). The primary endpoint is the Functional Ambulation Category (FAC) after 3 months. Secondary endpoints include FAC (after 15th therapy), 10-meter walk test (10MWT) (after 15th therapy, after 3 months), Timed Up and Go Test (TUG) (after 15th therapy and after 3 months, 3-months modified Rankin Scale (mRS), and Berg Balance Scale (BBS, after 15th therapy, after 3 months).

Conditions

Interventions

TypeNameDescription
PROCEDUREConventional rehabilitationPatients will undergo conventional rehabilitation
PROCEDURELeg/lower body exerciser device intervention.Patients will undergo leg/lower body exerciser device therapy.
PROCEDURELokomat interventionPatients will undergo therapy with Lokomat Pro FreeD device intervention.

Timeline

Start date
2022-05-01
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2021-06-02
Last updated
2023-09-21

Locations

1 site across 1 country: Czechia

Source: ClinicalTrials.gov record NCT04910217. Inclusion in this directory is not an endorsement.